FAIRBAIRN PLASTIC SURGERY LIMITED

Executive Summary

Fairbairn Plastic Surgery Limited exhibits a solid and improving financial position with growing net assets and healthy working capital, supported by timely filings and regulatory compliance. However, its limited operating history, small scale, and reliance on a very small team suggest a need for deeper operational and cash flow due diligence to fully assess sustainability and risk exposure.

View Full Analysis Report →

Company Analysis

This analysis is opinion only and should not be interpreted as financial advice.

FAIRBAIRN PLASTIC SURGERY LIMITED - Analysis Report

Company Number: SC682613

Analysis Date: 2025-07-29 20:59 UTC

  1. Risk Rating: LOW
    The company demonstrates solid net asset growth, positive working capital, and compliance with filing deadlines. The small scale and micro-entity reporting regime limits detailed financial disclosures but available data suggests sound financial health.

  2. Key Concerns:

  • Limited Scale and History: Incorporated in late 2020, the company has a relatively short operating history which may limit trend analysis and risk assessment depth.
  • Micro-Entity Reporting: Exemption from audit and simplified accounts restrict transparency, potentially obscuring detailed risk factors.
  • Single Employee and Director Concentration: Operational dependence on very few key individuals (one director also serving as secretary and only one employee) may pose continuity risks.
  1. Positive Indicators:
  • Improving Financial Position: Net assets increased from £17,668 in 2024 to £41,841 in 2025, with net current assets growing from £10,015 to £33,164, indicating strengthened liquidity.
  • Adequate Working Capital: Current assets approximately double current liabilities in the latest year, supporting short-term obligation coverage.
  • Regulatory Compliance: No overdue accounts or confirmation statements; filings are up to date, indicating good governance practices.
  • Clear Industry Focus: The company is classified under specialists medical practice activities (SIC 86220), suggesting a defined niche potentially benefiting from specialist demand.
  1. Due Diligence Notes:
  • Review Cash Flow Details: Verify underlying cash flows supporting current asset figures to confirm liquidity beyond balance sheet snapshots.
  • Understand Revenue and Profitability: Obtain detailed profit and loss data to assess operational sustainability and margin trends.
  • Evaluate Dependency on Key Personnel: Assess succession plans or risk mitigation for director/employee reliance.
  • Confirm No Undisclosed Liabilities: Given micro-entity exemptions, request supplementary disclosures or management representations on contingent liabilities or off-balance-sheet risks.

More Company Information


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company